compounding semaglutide fda news Warns on Certain Forms of Compounded FDA says 'no clinical need'
Description
Paying 1000 CAD monthly to lose 53 pounds works out to about 226 CAD per pound

9 Given the increasing offlabel use of GLP1RAs for weight management and the high prevalence of psychiatric comorbidities among individuals with metabolic disease, evaluating their neuropsychiatric safety and therapeutic potential is essential

May play an important role in intestinal mucosal growth in the early period of life

gallbladder issues and rare suicidal ideation flag the FDAs warning text

This is because they ultimately have limited effects in that most patients will not lose more than 15 or 20% of their body weight

2024;12:e5516
